May 16, 2026
Ro Khanna- Amount
- $1,001 to $15,000
- Filed
- Jul 6, 2026
Congress ticker disclosure profile
As of August 25 at 9:10 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference ZS. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
11
Member filers
4
Disclosed ranges
$114K
Most active member desks
6 buys vs 5 sells
Latest trade May 16, 2026
May 16, 2026
Ro KhannaJan 13, 2025
Rob BresnahanJun 21, 2024
Ro KhannaJun 20, 2024
Ro KhannaApr 10, 2023
Daniel GoldmanNov 3, 2022
Ro KhannaMay 5, 2022
Ro KhannaFeb 17, 2022
Ro KhannaJan 21, 2022
Ro KhannaJan 6, 2021
Thomas SuozziDec 11, 2020
Thomas Suozzi| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| May 16, 2026 | Ro Khanna | Buy | $1,001 to $15,000 | Jul 6, 2026 | Open card |
| Jan 13, 2025 | Rob Bresnahan | Sell | $1,001 to $15,000 | Feb 13, 2025 | Open card |
| Jun 21, 2024 | Ro Khanna | Buy | Receipt pending ingestion | Jul 8, 2024 | Open card |
| Jun 20, 2024 | Ro Khanna | Buy | Receipt pending ingestion | Jul 8, 2024 | Open card |
| Apr 10, 2023 | Daniel Goldman | Sell | $15,001 to $50,000 | May 19, 2023 | Open card |
| Nov 3, 2022 | Ro Khanna | Buy | Receipt pending ingestion | Dec 6, 2022 | Open card |
| May 5, 2022 | Ro Khanna | Sell | Receipt pending ingestion | Jun 10, 2022 | Open card |
| Feb 17, 2022 | Ro Khanna | Buy | Receipt pending ingestion | Mar 8, 2022 | Open card |
| Jan 21, 2022 | Ro Khanna | Sell | Receipt pending ingestion | Feb 8, 2022 | Open card |
| Jan 6, 2021 | Thomas Suozzi | Sell | $15,001 to $50,000 | Sep 23, 2021 | Open card |
| Dec 11, 2020 | Thomas Suozzi | Buy | $15,001 to $50,000 | Sep 23, 2021 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 5 of 11 filed rows include disclosed amount ranges (45%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.